Skip to content

Reduced Nicotine Cigarette Purchasing Decisions

Reduced Nicotine Cigarette Purchasing Decisions

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04999644
Enrollment
21
Registered
2021-08-11
Start date
2022-02-23
Completion date
2023-03-29
Last updated
2024-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder

Brief summary

The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.

Interventions

DRUGFull Nicotine Cigarettes

A full nicotine tobacco cigarette that will be smoked by participants

A reduced nicotine tobacco cigarette that will be smoked by participants

BEHAVIORALAverage Nicotine Expectancy

Participant instructed the cigarette is the same level of nicotine as your usual brand.

BEHAVIORALVery Low Nicotine Expectancy

Participant instructed the cigarette is a very low level of nicotine compared to your usual brand.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 21 years or older * Smoke five or more cigarettes per day for the past six months * Biological confirmation of cigarette use: have an expired carbon monoxide (CO) level of more than 8 ppm and a urinary cotinine level of more than 100 ng per milliliter at screening

Exclusion criteria

* Intention to quit smoking in the next 30 days * Weekly use of nicotine-containing products other than machine-manufactured combustible cigarettes * Serious medical or psychiatric disorder precluding participation by study physician guidance * Positive urine screening for illicit drugs other than cannabis or current substance use disorder * Women who are pregnant, plan to become pregnant, or are breast-feeding * Medical contraindications to receiving tobacco products

Design outcomes

Primary

MeasureTime frameDescription
Demand IntensityFour times over approximately two weeksConsumption of cigarettes at unconstrained price as measured by an incentivized demand task. Minimum value is 0, maximum value is not constrained. Higher scores indicate more cigarette consumption at unconstrained price (a worse outcome).
Demand ElasticityFour times over approximately two weeksChanges in cigarette consumption with changes in price as measured by an incentivized demand task. There is no minimum or maximum value. Higher scores indicate greater cigarette price sensitivity (a better outcome). Values are log-transformed. Data are presented for all subjects with non-zero data (zero data cannot be analyzed with a demand function so elasticity cannot be generated)

Secondary

MeasureTime frameDescription
Minnesota Nicotine Withdrawal ScalePost-cigarette administration four times over approximately two weeksA subjective effect measure of nicotine withdrawal. Minimum value is 0, maximum value is 68. Higher scores indicate greater nicotine withdrawal (a worse outcome).

Countries

United States

Participant flow

Participants by arm

ArmCount
Subjects Included in Analysis
This study used a within subjects design (i.e., all subjects were to receive all conditions). Twenty-one subjects completed the study.
21
Total21

Baseline characteristics

CharacteristicSubjects Included in Analysis
Age, Continuous48.7 years
STANDARD_DEVIATION 12
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
9 Participants
Region of Enrollment
United States
21 Participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
0 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

Demand Elasticity

Changes in cigarette consumption with changes in price as measured by an incentivized demand task. There is no minimum or maximum value. Higher scores indicate greater cigarette price sensitivity (a better outcome). Values are log-transformed. Data are presented for all subjects with non-zero data (zero data cannot be analyzed with a demand function so elasticity cannot be generated)

Time frame: Four times over approximately two weeks

Population: Data are presented for all subjects with non-zero data

ArmMeasureGroupValue (MEAN)Dispersion
Subjects Included in AnalysisDemand ElasticityCondition A: Told Full, Received Reduced-1.31 log(cigarettes/dollar)Standard Deviation 1.08
Subjects Included in AnalysisDemand ElasticityCondition B: Told Full, Received Full-1.45 log(cigarettes/dollar)Standard Deviation 0.5
Subjects Included in AnalysisDemand ElasticityCondition C: Told Reduced, Received Full-1.57 log(cigarettes/dollar)Standard Deviation 0.6
Subjects Included in AnalysisDemand ElasticityCondition D: Told Reduced, Received Reduced-1.26 log(cigarettes/dollar)Standard Deviation 1.17
Primary

Demand Intensity

Consumption of cigarettes at unconstrained price as measured by an incentivized demand task. Minimum value is 0, maximum value is not constrained. Higher scores indicate more cigarette consumption at unconstrained price (a worse outcome).

Time frame: Four times over approximately two weeks

ArmMeasureGroupValue (MEAN)Dispersion
Subjects Included in AnalysisDemand IntensityCondition A: Told Full, Received Reduced6.48 cigarettesStandard Error 4.55
Subjects Included in AnalysisDemand IntensityCondition B: Told Full, Received Full8.10 cigarettesStandard Error 6.61
Subjects Included in AnalysisDemand IntensityCondition C: Told Reduced, Received Full7.81 cigarettesStandard Error 5.63
Subjects Included in AnalysisDemand IntensityCondition D: Told Reduced, Received Reduced6.48 cigarettesStandard Error 4.91
Secondary

Minnesota Nicotine Withdrawal Scale

A subjective effect measure of nicotine withdrawal. Minimum value is 0, maximum value is 68. Higher scores indicate greater nicotine withdrawal (a worse outcome).

Time frame: Post-cigarette administration four times over approximately two weeks

ArmMeasureGroupValue (MEAN)Dispersion
Subjects Included in AnalysisMinnesota Nicotine Withdrawal ScaleCondition A: Told Full, Received Reduced5.67 units on a scaleStandard Deviation 6.95
Subjects Included in AnalysisMinnesota Nicotine Withdrawal ScaleCondition B: Told Full, Received Full5.14 units on a scaleStandard Deviation 6.54
Subjects Included in AnalysisMinnesota Nicotine Withdrawal ScaleCondition C: Told Reduced, Received Full4.33 units on a scaleStandard Deviation 4.95
Subjects Included in AnalysisMinnesota Nicotine Withdrawal ScaleCondition D: Told Reduced, Received Reduced6.24 units on a scaleStandard Deviation 6.47

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026